Non-Survivors (21) | Survivors (15) | p-value | |
---|---|---|---|
Demographics | |||
Weight (kg), Median (IQR) | 65.8 (56–93) | 67 (59–88.6) | 0.748 |
Age (years), Median (IQR) | 48 (29–56) | 32 (24–55) | 0.194 |
Female, n (%) | 5 (24) | 4 (27) | 0.57 |
Ethnicity, n (%) | |||
Asian | 0 (0) | 1 (7) | 0.682 |
Black | 13 (62) | 9 (60) | |
Hispanic | 2 (10) | 2 (13) | |
Unknown | 1 (5) | 0 (0) | |
White | 5 (24) | 3 (20) | |
Pre-ECMO Cardiac Parameters | |||
Systolic blood pressure (mmHg), median (IQR) | 87.5 (73.5–95.25) | 86 (68.5–107) | 0.884 |
Diastolic blood pressure (mmHg), median (IQR) | 53 (47.5–57.25) | 58.5 (52.25–69.25) | 0.078 |
Adjunct Pre-VA ECMO Treatment, n (%) | |||
Vasopressor/inotropic drugs* | 19 (90) | 6 (40) | 0.0024 |
Cardiopulmonary bypass | 2 (10) | 2 (13) | 1 |
Intra-aortic balloon | 3 (14) | 2 (13) | 1 |
Nitric oxide | 2 (10) | 1 (7) | 1 |
Neuromuscular blockers | 6 29) | 1 (7) | 0.2 |
Bicarbonate (Intravenous) | 5 (24) | 2 (13) | 0.67 |
Renal Replacement Therapy | 4 (19) | 1 (7) | 0.38 |